Industry News - Tag: Stada

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Stada’s Consumer Healthcare sales rise by 15%
Premium

22 March 2022

Stada’s Consumer Healthcare segment reported sales up by 15% to EUR1.28 billion (USD1.40 billion) in 2021, accounting for two-fifths of the company’s total sales. The German company says it expects to “withstand the current economic issues in Russia”.

Read the full story

Stada welcomes German decision on doxylamine
Premium

2 March 2022

Stada has welcomed a decision by the German health ministry to allow the antihistamine doxylamine to remain available without a prescription for use by people of all ages with sleep disorders, including those aged 65 years and older.

Read the full story